首页> 外文期刊>Cancer investigation >Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma
【24h】

Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma

机译:中性粒细胞与淋巴细胞之比(NLR)和衍生的中性粒细胞与淋巴细胞之比(d-NLR)预测接受新辅助放射化学疗法治疗直肠腺癌后接受根治性手术的患者的无反应者和术后并发症

获取原文
获取原文并翻译 | 示例
       

摘要

In order to evaluate neutrophil-to-lymphocyte ratio (NLR) and derived neutrophil-to-lymphocyte ratio (d-NLR) in predicting response and complications in rectal cancer patients who underwent surgery after neo-adjuvant radio-chemotherapy, 87 patients were evaluated. Cutoffs before and after radio-chemotherapy were respectively 2.8 and 3.8 for NLR, and 1.4 and 2.3 for d-NLR. They were analyzed in relation to clinical and pathological outcomes. Patients with preoperative NLR and d-NLR higher than cutoffs had significantly higher rates of tumor regression grade response (TRG 4) and postoperative complications. Elevated NLR and d-NLR after radio-chemotherapy are associated with worse pathological and clinical outcome.
机译:为了评估中性粒细胞与淋巴细胞之比(NLR)和衍生的中性粒细胞与淋巴细胞之比(d-NLR)在预测新辅助放化疗后手术的直肠癌患者的反应和并发症中的应用,评估了87例患者。放化疗前后,NLR的临界值分别为2.8和3.8,d-NLR的临界值为1.4和2.3。对它们的临床和病理结果进行了分析。术前NLR和d-NLR高于临界值的患者的肿瘤消退等级反应(TRG 4)和术后并发症的发生率显着更高。放化疗后NLR和d-NLR升高与病理和临床预后差有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号